Mechanism of action of three newly registered drugs for multiple sclerosis treatment.
about
Treatment of Theiler's virus-induced demyelinating disease with teriflunomide.Redox Regulation of Inflammatory Processes Is Enzymatically Controlled.Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.Beneficial or Harmful Role of Macrophages in Guillain-Barré Syndrome and Experimental Autoimmune Neuritis.
P2860
Mechanism of action of three newly registered drugs for multiple sclerosis treatment.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Mechanism of action of three newly registered drugs for multiple sclerosis treatment.
@en
Mechanism of action of three newly registered drugs for multiple sclerosis treatment.
@nl
type
label
Mechanism of action of three newly registered drugs for multiple sclerosis treatment.
@en
Mechanism of action of three newly registered drugs for multiple sclerosis treatment.
@nl
prefLabel
Mechanism of action of three newly registered drugs for multiple sclerosis treatment.
@en
Mechanism of action of three newly registered drugs for multiple sclerosis treatment.
@nl
P50
P1476
Mechanism of action of three newly registered drugs for multiple sclerosis treatment.
@en
P2093
Dagmara Mirowska-Guzel
Kaja Kasarełło
P304
P356
10.1016/J.PHAREP.2017.02.017
P577
2017-02-22T00:00:00Z